Teva
Top Ten most popular articles on Pharmafile.com this week
April 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Cancer, Humira, Mylan, Novartis, Shire, Takeda, Teva, acquisition, cystic fibrosis, hepatitis C, pharma, top ten
It’s Friday the 13th, but that doesn’t change a strong showing from the industry this week as it continued to …
Mylan looks to hit Teva where it hurts, eyeing slow-release MS treatment
April 11, 2018Research and Development, Sales and Marketing Copaxone, Mapi Pharma, Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Mylan has taken several steps recently that seem intended to hit sales of its big rivals on their key products, …
Teva spared payout to GSK over patent infringement dispute
March 29, 2018Sales and Marketing Coreg, GSK, GlaxoSmithKline, Teva, carvedilol, heart failure, pharma
Teva has been spared a sizeable payout to GlaxoSmithKline after a federal judge overturned a US jury verdict demanding that …
InSight Innovations to buy CureTech in $550m deal
March 28, 2018Research and Development, Sales and Marketing Cancer, CureTech, Insight Innovations, Pfizer, Teva, brain cancer, brain tumour, immunotherapy, israel
Israeli drug firm CureTech is be sold for the third time in four years, this time to InSight Innovations in …
Teva denies wrongdoing in Cephalon pay-to-delay deal hearing
March 14, 2018Research and Development, Sales and Marketing Cephalon, Pay to delay, Provogil, Teva, pay-to-delay, pharma
Teva has denied allegations from the European Commission (EC) that it engaged in illegal anti-competitive pay-to-delay tactics to maintain its …
Migraine drug bad news hits a weakened Teva
February 9, 2018Medical Communications, Sales and Marketing CGRP, Teva, biotech, drugs, pharma, pharmaceutical
The cacophony of bad news that Teva has received in 2017 really needs no retelling, anyone following the story of …
Working Life: Marco Avila, Vice President of Medical Affairs, Teva Europe
February 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, Working Life
Pharmafile.com met with Marco Avila, Vice President of Medical Affairs at Teva Europe to discuss his life in the industry, …
Apotex President resigns amidst Founder’s murder and allegations of accepting Teva secrets
January 30, 2018Manufacturing and Production, Medical Communications Apotex, Jeremy Desai, Teva, pharma
Following the alleged murder of its founder Barry Sherman and his wife in December last year, Canada’s largest generic drug …
More woes for Teva as two late-stage asthma studies bomb
January 23, 2018Manufacturing and Production, Research and Development Teva, asthma, pharma
In yet more bad news for Teva, it has emerged that two of the firm’s late-stage studies in asthma have …
FDA expands indication of Teva’s Trisenox for acute promyelocytic leukaemia
January 16, 2018Manufacturing and Production, Sales and Marketing FDA, Teva, acute promyelocytic leukaemia, leukaemia, pharma
Teva has announced that its Trisenox (arsenic trioxide) injection has been awarded US approval from the FDA in combination with …
Teva settles with Israeli authorities over international bribery
January 15, 2018Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical
Just over a year ago, Teva closed a case with US authorities by agreeing to pay a $519 million fine …
Top Ten most popular articles on Pharmafile.com this week
January 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, HIV, J&J, JJ, Johnson & Johnson, Pfizer, Shire, Teva, Xarelto, patient reported outcomes
The Xmas break is now a distant memory as we move further into January, and with another Friday comes another …
Teva execs feel the pinch, after pay halved
January 11, 2018Medical Communications, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical
Teva’s current crisis is built upon problems that run deep into the company, after numerous acquisitions left it bloated and …
Pharmafile.com’s top ten stories of 2017
December 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Actelion, Amgen, AstraZeneca, Cyber attack, EMA, European Commission, Humira, J&J, JJ, Johnson & Johnson, MSD, Sanofi, Shire, Teva, biosimilar, brexit
After a packed year that has flown by, we’ve reached the final top ten of 2017. Below you can find …
Top Ten most popular articles on Pharmafile.com this week
December 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ionis, Sanofi, Teva, haemophilia, pharma, top ten
Just 10 days away from Christmas, and big news is still flowing in the industry. Sanofi remains embroiled in scandal …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
